KSE - Delayed Quote KRW

Chong Kun Dang Pharmaceutical Corp. (185750.KS)

Compare
89,600.00 +500.00 (+0.56%)
At close: January 3 at 3:30:10 PM GMT+9

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.
NameTitlePayExercisedYear Born
Mr. Young-Joo Kim President, CEO & Chairman -- -- --

Chong Kun Dang Pharmaceutical Corp.

8, Chungjeong-ro
Seodaemun-gu
Seoul
South Korea
82 2 6373 0600 https://www.ckdpharm.com
Sector: 
Healthcare
Full Time Employees: 
2,286

Description

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. It provides prescription drugs for anticancer, anti-hypertension, anti-hyperlipidemia, anti-diabetic, and immunosuppressant products; over-the-counter drugs for therapeutic benefits, supplements, and other preventive products; health supplements with preventive benefits, including prebiotics and vitamins with Omega-3; and consumer health products, such as red-ginseng healthy drink, hand sanitizer, and hair color medication, as well as insecticides. The company also exports its products. Chong Kun Dang Pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.

Corporate Governance

Chong Kun Dang Pharmaceutical Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 3, 2025 at 10:59 AM UTC - February 7, 2025 at 12:00 PM UTC

Chong Kun Dang Pharmaceutical Corp. Earnings Date

Recent Events

December 27, 2023 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers